Clinical Trials Logo

Clinical Trial Summary

Premature coronary heart disease (CHD) refers to the onset of myocardial infarction in men < 55 years old, women < 65 years old. At present, researches on early-onset coronary heart disease mostly focus on its risk factors and clinical characteristics, but there is no relevant research on the relationship between early-onset myocardial infarction and atherosclerosis.


Clinical Trial Description

Premature coronary heart disease is defined as the first onset of male < 55 years old, female < 65 years old, confirmed by clinical examination. A number of studies have found that smokers have a significantly increased risk of acute myocardial infarction, and suggest that continued smoking is still an independent predictor of mace. These findings suggest that smoking is significantly associated with early-onset coronary heart disease. A number of studies have found that smoking can increase peripheral arterial stiffness. At present, there is no study on peripheral arterial stiffness in patients with early-onset myocardial infarction, so we suspect that peripheral arterial stiffness in patients with early-onset myocardial infarction is significantly increased ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04578522
Study type Observational
Source Chongqing Medical University
Contact Dongying Zhang, doctor
Phone +8613608398395
Email zdy.chris@qq.com
Status Recruiting
Phase
Start date September 29, 2020
Completion date September 29, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04613167 - Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment N/A
Not yet recruiting NCT06164730 - A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease Phase 1